BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36970891)

  • 1. Shear stimulated red blood cell microparticles: Effect on clot structure, flow and fibrinolysis.
    Buerck JP; Foster KM; Larson PR; O'Rear EA
    Biorheology; 2023; 59(1-2):43-59. PubMed ID: 36970891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxaban.
    Varin R; Mirshahi S; Mirshahi P; Klein C; Jamshedov J; Chidiac J; Perzborn E; Mirshahi M; Soria C; Soria J
    Thromb Res; 2013 Mar; 131(3):e100-9. PubMed ID: 23313382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MASP-1 of the complement system alters fibrinolytic behaviour of blood clots.
    Jenny L; Noser D; Larsen JB; Dobó J; Gál P; Pál G; Schroeder V
    Mol Immunol; 2019 Oct; 114():1-9. PubMed ID: 31325724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Microparticles Alter Formation, Structure, and Properties of Fibrin Clots.
    Zubairova LD; Nabiullina RM; Nagaswami C; Zuev YF; Mustafin IG; Litvinov RI; Weisel JW
    Sci Rep; 2015 Dec; 5():17611. PubMed ID: 26635081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood clot contraction differentially modulates internal and external fibrinolysis.
    Tutwiler V; Peshkova AD; Le Minh G; Zaitsev S; Litvinov RI; Cines DB; Weisel JW
    J Thromb Haemost; 2019 Feb; 17(2):361-370. PubMed ID: 30582674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxynitrite may affect fibrinolysis via the reduction of platelet-related fibrinolysis resistance and alteration of clot structure.
    Misztal T; Rusak T; Brańska-Januszewska J; Ostrowska H; Tomasiak M
    Free Radic Biol Med; 2015 Dec; 89():533-47. PubMed ID: 26454084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The myeloperoxidase product, hypochlorous acid, reduces thrombus formation under flow and attenuates clot retraction and fibrinolysis in human blood.
    Misztal T; Golaszewska A; Tomasiak-Lozowska MM; Iwanicka M; Marcinczyk N; Leszczynska A; Chabielska E; Rusak T
    Free Radic Biol Med; 2019 Sep; 141():426-437. PubMed ID: 31279970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [THROMBIN-MEDIATED EFFECTS OF BLOOD MICROPARTICLES ON FORMATION, STRUCTURE, AND STABILITY OF FIBRIN CLOTS].
    Nabiullina RM; Mustafin IG; Ataullakhanov FI; Litvinov RI; Zubairova LD
    Ross Fiziol Zh Im I M Sechenova; 2015 Jul; 101(7):812-21. PubMed ID: 26591054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.
    Tantawy AA; Adly AA; Ismail EA; Habeeb NM; Farouk A
    Platelets; 2013; 24(8):605-14. PubMed ID: 23249216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spatial dynamics of fibrin clot dissolution catalyzed by erythrocyte-bound vs. free fibrinolytics.
    Gersh KC; Zaitsev S; Muzykantov V; Cines DB; Weisel JW
    J Thromb Haemost; 2010 May; 8(5):1066-74. PubMed ID: 20149071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomaterial Wettability Affects Fibrin Clot Structure and Fibrinolysis.
    Ruhoff AM; Hong JK; Gao L; Singh J; Tran C; Mackie G; Waterhouse A
    Adv Healthc Mater; 2021 Oct; 10(20):e2100988. PubMed ID: 34423587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing interactions of red blood cells and contracting fibrin platelet clots.
    Sun Y; Le H; Lam WA; Alexeev A
    Biophys J; 2023 Nov; 122(21):4123-4134. PubMed ID: 37598293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking.
    Byrnes JR; Duval C; Wang Y; Hansen CE; Ahn B; Mooberry MJ; Clark MA; Johnsen JM; Lord ST; Lam WA; Meijers JC; Ni H; Ariëns RA; Wolberg AS
    Blood; 2015 Oct; 126(16):1940-8. PubMed ID: 26324704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and biophysical conditions for blood clot lysis.
    Sabovic M; Blinc A
    Pflugers Arch; 2000; 440(5 Suppl):R134-6. PubMed ID: 11005642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherent fibrin fiber tension propels mechanisms of network clearance during fibrinolysis.
    Cone SJ; Fuquay AT; Litofsky JM; Dement TC; Carolan CA; Hudson NE
    Acta Biomater; 2020 Apr; 107():164-177. PubMed ID: 32105833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin Modulates Shear-Induced NETosis in Sterile Occlusive Thrombi Formed under Haemodynamic Flow.
    Yu X; Diamond SL
    Thromb Haemost; 2019 Apr; 119(4):586-593. PubMed ID: 30722079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII.
    Rijken DC; Abdul S; Malfliet JJ; Leebeek FW; Uitte de Willige S
    J Thromb Haemost; 2016 Jul; 14(7):1453-61. PubMed ID: 27148673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis.
    Kwasny-Krochin B; Gluszko P; Undas A
    Thromb Res; 2010 Jul; 126(1):e11-6. PubMed ID: 20471669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced plasma fibrin clot permeability and susceptibility to lysis are associated with increased risk of postthrombotic syndrome.
    Siudut J; Grela M; Wypasek E; Plens K; Undas A
    J Thromb Haemost; 2016 Apr; 14(4):784-93. PubMed ID: 26786481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of fibrin formation and fibrinolytic function in patients with the antiphospholipid syndrome.
    Vikerfors A; Svenungsson E; Ågren A; Mobarrez F; Bremme K; Holmström M; Eelde A; Bruzelius M; Elgue G; Wallén H; Antovic A
    Thromb Res; 2014 May; 133(5):936-44. PubMed ID: 24630645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.